Last reviewed · How we verify
broncho-alveolar lavage sampling
At a glance
| Generic name | broncho-alveolar lavage sampling |
|---|---|
| Sponsor | Assistance Publique Hopitaux De Marseille |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Innate Immune Response During Community Acquired Pneumonia
- Clinical, Radiological, Tissue and Biological Phenotyping for the Analysis of the Transition From Physiology to Pathology in Pulmonary Diseases With Pulmonary Hypertension
- Characterizing the Human Airway Immune Response to FluMist Vaccination (PHASE4)
- Bronchial Washing Beforeand After Endobronchial Biopsy and Bronchial Brushing (NA)
- Pulmonary Effects of 100% Biodiesel Exhaust (NA)
- Impaired Secretory IgA and Mucosal Immunity in Cystic Fibrosis
- Assessment of the Diagnostic Capacity of the Mini-broncho Alveolar Lavage Performed Through a Suction Catheter (NA)
- EBUS-Guided TBNA Increases the Diagnostic Yield of Peripheral Pulmonary Lesions (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |